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Abstract
Creutzfeldt-Jakob disease (CJD) should still be considered in a patient presenting
with rapidly progressive dementia and negative CSF 14-3-3 protein and RT-QulC.
Treatable causes of encephalopathy must be ruled out. Neurodegenerative diseases
must also be considered.
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IN T RO D U C T ION

Creutzfeldt-Jakob disease, while rare, is the most common
human prion disease (proteinaceous and infectious) which
results in rapidly progressive dementia. It remains incurable with mortality typically within 12 months of diagnosis.
Patients with CJD have a mutated form of PrP (PrPSc). PrPC
is a normal, cell surface glycoprotein formed in the brain and
guts with unknown normal function. PrPSc is synthesized in
large quantities results in exponential misfolding and neurodegeneration. The proposed mechanism suggests the alpha
helical regions of PrPC bind to the beta pleated sheets of PrPSc
and continue to propagate, similar to Alzheimer's disease and
Parkinson's disease. Etiology for the mutated protein varies
based on CJD type.1,2
Creutzfeldt-Jakob disease is the cause of 1/6000-1/10 000
death per year in United States.
Three types of CJD exist1,2:

1. Sporadic CJD (sCJD) (85%-90%). It occurs without any
identifiable pattern and appears to be a spontaneous mutation of PrP. Worldwide incidence is 1-1.5 per 1 000 000
annually. The average age at death is 68 years old.
2. Genetic or familial CJD (5%-15%). Two distinct forms
are Gerstmann-Straussler-Scheinker syndrome and fatal
familial insomnia. Both are more typical, rapidly progressive forms of the disease.
3. Infectious CJD includes dietary and iatrogenic (<1%).
Dietary include two types: kuru and variant CJD. Kuru was
found exclusively in a New Guinea tribe with supposed
transmission via ritualistic cannibalistic practice.2 Variant
CJD (vCJD), also known as “Mad Cow Disease,” was discovered in more than 200 people in Great Britain in 1994
who had eaten beef contaminated with the prion disease
bovine spongiform encephalopathy. The disease manifested
10 years after an outbreak was observed in cattle.2 Moreover,
iatrogenic cases of CJD have been recognized in patients
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who underwent cadaveric dura grafts, human growth hormone injections, corneal transplants, and procedures using
contaminated neurosurgical instruments.1
Creutzfeldt-Jakob disease may present with a prodrome of
decreased concentration, memory loss, depression, and anxiety. As the disease progresses, affected patients may develop
myoclonus, extrapyramidal symptoms, akinetic mutism, visual impairments, hypersomnia, psychiatric manifestation,
and cerebellar disturbances. These patients progressively
decline cognitively and functionally eventually becoming comatose then dying. Definitive diagnosis is by neuropathological, immunocytochemically, Western blot confirmed PrPSc
or presence of scrapie-associated fibrils. Probable diagnosis,
after ruling out other etiologies, is by neuropsychiatric disorder, plus RT-QulC analysis (99%-100% specific) OR at
least two of myoclonus, visual or cerebellar signs, pyramidal/
extrapyramidal signs, akinetic mutism AND at least one of
typical EEG, positive CSF 14-3-3 protein, or positive MRI.1
To date, there is no effective treatment; disease is uniformly
fatal.
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He traveled to El Salvador 1 year prior to presentation. There
are no recent sick or animal contacts.
At our hospital, he was never febrile with stable vital
signs. After his initial negative MRI at the outside facility,
MRI head began to show bilateral caudate and basal ganglia
abnormality on T2 as well as DWI. Additionally, there is a
cortical ribbon involvement in the posterior portion of both
hemispheres (Figure 1A,B). There was never any pulvinar

(A)

CA S E RE P O RT

A 53-year-old male was brought to our Emergency
Department with 1 month of confusion. He was completely
normal 1 month prior, running a successful small business.
The patient's wife initially observed confusion which worsened with impaired functioning, impairing his ability to work
and care for his children. The patient was initially brought to
an outside facility around 2 weeks into this illness. At that
time, his symptoms had progressed to difficulty recognizing family, mutism, and hypersomnia. He then developed
myoclonus with agitation and combativeness. MRI and CSF
analysis from the outside facility were unremarkable (including an initially unavailable report of “unlikely prion disease”
with no 14-3-3 protein detected). The patient was released
with eventual admission to our hospital. By week 4 of his
disease, he became bedridden, disoriented, and unable to
recognize family. He developed myoclonic jerks and did not
follow commands. Moreover, he had moderately increased
muscle tone and incontinence. He never developed psychiatric manifestations. His clinical course continued to decline
with subsequent intubation for airway protection by week 5
with deterioration by week 6 to GCS of 1/1/1. He has remained in this state ever since.
Past medical history was significant for remote history of
nasal carcinoma. The patient took no home medications. His
surgical history was significant for nasal carcinoma resection. Family history consisted of a father with hypertension.
The patient denied using tobacco or drugs and used alcohol
socially only. He ran a busy automobile mechanic business.

(B)

F I G U R E 1 A, MRI abnormal signal density on bilateral caudate
and basal ganglia on DWI. B, MRI abnormal signal density on bilateral
caudate and basal ganglia on T2
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involvement. Routine complete blood count, complete metabolic panel, and coagulation studies were within normal
limits. Serum analysis showed normal levels of vitamin B12,
folate, methyl malonic acid, C-reactive protein, erythrocyte
sedimentation rate, Cryptococcus antigen screen, Treponema
antibody EIA, and ceruloplasmin. N-methyl D-aspartate
(NMDA) receptor antibodies and antineuronal antibody panel
were negative. HIV was non-reactive. EEGs showed periodic
synchronized electric discharges which were refractory to
antiepileptic drugs (Figure 2). Repeat lumbar puncture was
performed and showed WBC 86/mm3 with 38% neutrophils,
34% lymphocytes, and 8% bands, RBC 3048 mm3, glucose
level of 104 mg/dL, and protein level 100 mg/dL. CSF herpes
simplex virus PCR, VDRL syphilis screen, West Nile IgM
and IgG ELISA, and AFB stain were all negative. Cytology
showed inflammatory cells but no malignant cells. Repeat
CSF 14-3-3 protein and RT-QuIC collected at 4 week after
initial symptoms finally came back positive with probability of prion disease >98%. Brain biopsy, although requested,
never took place.
After 2 months of acute hospitalization but continued
stability, patient was placed at a nearby subacute facility.
Follow-up visits show no change nor deterioration. Patient

FIGURE 2
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remains on mechanical ventilation via tracheostomy and tube
feeding at 3 year point from original symptoms.
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DISCUSSION

Although CJD is a rare disease, it should be considered
when a patient is presenting with a rapidly progressive
dementia. Treatable causes of encephalopathy such as
meningitis, meningoencephalitis, CNS vasculitis, hypothyroidism, sarcoidosis, toxicities, paraneoplastic syndromes, and primary neoplasms must be ruled out.2,3
Neurodegenerative diseases such as Alzheimer's disease,
dementia with Lewy bodies,2-5 frontotemporal dementia,
corticobasilar degeneration, and progressive supranuclear
palsy must also be considered.2,3 sCJD has even presented
as a stroke.5
Considering rapidly progressive dementia, myoclonus,
akinesia, mutism, positive CSF 14-3-3 protein and RT-QulC,
MRI high-intensity signal abnormalities in the caudate nucleus on DWI and routine investigations that do not indicate
an alternative diagnosis, the diagnosis of the patient is CJD,
most probably the sporadic type.8

EEG showing periodic synchronized electric discharges on multiple EEGs refractory to seizure medication
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F I G U R E 3 Proposed diagnostic pathway for the workup of a patient with rapidly progressive cognitive decline. NMDAR, N-methyl-Daspartate receptor; VGKC, voltage-gated potassium channel (Source: https://thejns.org/focus/view/journals/neurosurgfocus/39/5/article-pE2.xml or
https://doi.org/10.3171/2015.8.FOCUS15328)

This patient case was remarkable in his progressive dementia
given its uniquely significant rapidity over 6 weeks. Typically,
onset of symptoms from presentation to a hospital ranges from

2 months to 2 years.3-4,6,7 This patient's progression was so
rapid that he became irreversibly comatose significantly prior
to the turnaround time of CSF prion analysis. Furthermore, his
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CSF yielded no such protein when he was 2 weeks into his rapid
deterioration. These discrepancies confounded the initial diagnosis. This case is also remarkable that the patient is still alive
at the 3-year point. sCJD has been documented to run a faster
course than vCJD yet our patient does not have vCJD given
no pulvinar sign and lack of psychiatric manifestations dominating the course of disease. Previous literature notes a patient
with sCJD who had survived for 2 and a half years.9 Although
the gold standard for diagnosis is tissue pathological confirmation, but brain biopsy was not performed at the early stages of
diagnosis due to failure of securing neurosurgical service and
facility, which is not uncommon at the community hospital settings. Later in the diagnosis process when CSF markers became
positive, indication for brain biopsy was not justified considering risk-benefit assessment, low sensitivity, and no change in
treatment regardless of the result (Figure 3).10 Our patient is
surviving beyond 3 years currently. He continues to remain unusual in his rapidity, development, and longevity.
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CO NC LU SION S

Physicians should be aware that for a patient presenting with
rapidly progressive dementia, Creutzfeldt-Jakob Disease
(CJD) should be included as one of the differential diagnoses.
Since CJD can present with various forms of symptoms, and
although a rare disease, it should not be ruled out by negative
laboratory results and images. The gold standard diagnosis is
confirmation by brain biopsy, but due to restrictions for operating room sterilizations, low sensitivity, high morbidity, and
the fact that the positive result does not change the treatment
in most cases, brain biopsy is not routinely done. It is very
important to rule out treatable diseases in differential diagnosis such as meningitis, meningoencephalitis, CNS vasculitis,
hypothyroidism, sarcoidosis, toxicities, paraneoplastic syndromes, and primary neoplasms. Our case depicts a case CJD
in a fully functional patient who declined to a comatose state
in 6 weeks. Although negative on initial workup, CSF 143-3 protein, and RT-QulC became positive well over 6 weeks
into his illness. This initial progression is unusually rapid.
However, as of this article's submission date, the patient is
still alive at a subacute facility 3 years after diagnosis. Both
the rapid deterioration and protracted survival are atypical.
CONFLICT OF INTEREST
None declared.
AUTHOR CONTRIBUTIONS
AL: was the principal investigator and the attending neurologist, realized the presentation/time frame is abnormal, and

|

5

initiated the write-up. JC: was a resident treating the patient
and working under Dr Liu, who did initial literature search
and came up with the first draft. BK: was a resident working
under Dr Liu, who contributed to the revision. AA: worked
under Dr Liu's supervision on the final revision of the paper.
ORCID
Brian Khong
https://orcid.org/0000-0002-8975-3804
Amin Abolfazli
https://orcid.org/0000-0001-9880-2279
Antonio Liu
https://orcid.org/0000-0002-1932-7308
R E F E R E NC E S

1. Department of Health and Human Services, Centers for Disease
Control and Prevention. Creutzfeldt-Jakob disease, classic (CJD).
https://www.cdc.gov/prions/cjd/index.html. Accessed August 31,
2019.
2. Goldman L, Bosque PJ, Schafer AI. Chapter 415, Prion diseases.
In: Cecil RL, ed. Goldman-Cecil Medicine, Vol. 2, 25th edn.
Philadelphia: Elsevier/Saunders; 2016:2504-2505.
3. Kojima G, Tatsuno B, Inaba M, et al. Creutzfeldt - Jakob disease: a
case report and differential diagnosis. Hawaii J Med Public Health.
2013;72(4):136-139.
4. Saint-Aubert L, Pariente J, Dumas H, et al. Case report of Lewy
body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old
man. BMC Neurol. 2016;16(1):122.
5. Tsivgoulis G, Bonakis A, Papathanasiou MA, et al. Magnetic
resonance imaging reveals Creutzfeldt-Jakob disease in a patient with apparent dementia with Lewy bodies. J Neurol Sci.
2014;340(1-2):130-132.
6. Sharma D, Boggild M, van Heuven A, et al. Creutzfeldt-Jakob disease presenting as stroke. Neurologist. 2017;22(2):48-52.
7. Atalay FO, Tolunay S, Ozgun G, Bekar A, Zarifoglu M. CreutzfeldtJakob disease: report of four cases and review of the literature. Turk
J Pathol. 2013;31:148-152.
8. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain.
2009;132(Pt 10):2659-2668.
9. Qaiser J, Faouzi A, et al. An unusual case of sporadic CreutzfeldtJakob disease. BMJ Case Rep. 2010;2010:bcr12.2009.2567.
10. Manix M, Kalakoti P, Henry M, et al. Creutzfeldt-Jakob disease updated diagnostic criteria, treatment algorithm, and the utilit utility
of brain biopsy. Neurosurg Focus. 2015;39(5):E2.

How to cite this article: Christopher JK, Khong B,
Abolfazli A, Liu A. Comatose within 6 weeks, but
still alive after 3 years, Creutzfeldt-Jakob disease with
unusual progression. Clin Case Rep. 2020;00:1–5.
https://doi.org/10.1002/ccr3.2807

